Home > PRODUCTS > Focused libraries > Other

Design your focused library

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.

Other Focused Libraries

Other focused libraries

101 uncategorized Focused Libraries designed with Ligand-based approach are listed below. These libraries are proposed for screening in various research and drug development projects.







  • the libraries contain drug-like compounds only
  • all the compounds are in stock
  • cherry picking is available


You can sort data by any column and use "Filter" option to search library's name:

Loading data...
Name Number of compounds Approach
Acetylcholine M2 receptor antagonist - Ligand-based
Acetylcholine M3 receptor antagonist - Ligand-based
Acetylcholinesterase (AChE) 828 Receptor-based
Acetylcholine muscarinic antagonist - Ligand-based
Alpha 1 adrenoreceptor agonist - Ligand-based
Alpha 1 adrenoreceptor antagonist - Ligand-based
Alpha 1a adrenoreceptor antagonist - Ligand-based
Alpha 2 adrenoreceptor agonist - Ligand-based
Alpha adrenoreceptor agonist - Ligand-based
Alpha adrenoreceptor antagonist - Ligand-based
Dopamine autoreceptor agonist - Ligand-based
Dopamine D3 agonist - Ligand-based
Dopamine D3 antagonist - Ligand-based
Dopamine D4 antagonist - Ligand-based
Endothelin A receptor antagonist - Ligand-based
Endothelin B receptor antagonist - Ligand-based
Endothelin receptor antagonist - Ligand-based
GABA A receptor agonist - Ligand-based
Glucagon receptor antagonist - Ligand-based
2,3 Oxidosqualene lanosterol cyclase inhibitor - Ligand-based
5 Hydroxytryptamine 1 antagonist - Ligand-based
5 Hydroxytryptamine 1A agonist - Ligand-based
5 Hydroxytryptamine 1D antagonist - Ligand-based
5 Hydroxytryptamine 2 agonist - Ligand-based
5 Hydroxytryptamine 2A antagonist - Ligand-based
5 Hydroxytryptamine 2C antagonist - Ligand-based
5 Hydroxytryptamine 3 agonist - Ligand-based
5 Hydroxytryptamine antagonist - Ligand-based
5 Hydroxytryptamine uptake inhibitor - Ligand-based
Acetyl CoA transferase inhibitor - Ligand-based
Acetylcholine nicotinic agonist - Ligand-based
Acetylcholine nicotinic antagonist - Ligand-based
Acute neurologic disorders treatment - Ligand-based
ADP ribose polymerase inhibitor - Ligand-based
Adrenaline antagonist - Ligand-based
Adrenaline uptake inhibitor - Ligand-based
Aldose reductase inhibitor - Ligand-based
Anti-Helicobacter pylori - Ligand-based
Benzodiazepine agonist - Ligand-based
Benzodiazepine agonist partial - Ligand-based
Corticotropin releasing factor 1 receptor antagonist - Ligand-based
Cyclic GMP phosphodiesterase inhibitor - Ligand-based
Cyclooxygenase inhibitor - Ligand-based
Dihydroorotate dehydrogenase inhibitor - Ligand-based
Dihydropteroate synthase inhibitor - Ligand-based
DNA topoisomerase inhibitor - Ligand-based
Endothelial growth factor antagonist - Ligand-based
Excitatory amino acid antagonist - Ligand-based
Factor VIIa inhibitor - Ligand-based
Gastrin inhibitor - Ligand-based
Growth hormone agonist - Ligand-based
Histamine antagonist - Ligand-based
Histamine release inhibitor - Ligand-based
Interleukin 8 antagonist - Ligand-based
Irritable Bowel syndrome treatment - Ligand-based
Kallikrein inhibitor - Ligand-based
Lactamase C inhibitor - Ligand-based
Leukotriene B4 antagonist - Ligand-based
Leukotriene E4 antagonist - Ligand-based
Lipase inhibitor - Ligand-based
Lipid peroxidase inhibitor - Ligand-based
Lipoxygenase inhibitor - Ligand-based
Liver fibrosis treatment - Ligand-based
Maillard reaction inhibitor - Ligand-based
MAO inhibitor - Ligand-based
Mediator release inhibitor - Ligand-based
Neurokinin 1 antagonist - Ligand-based
Neurokinin 3 antagonist - Ligand-based
Neuropeptide antagonist - Ligand-based
Neuropeptide Y antagonist - Ligand-based
Non-steroidal antiinflammatory agent - Ligand-based
Oxytocin antagonist - Ligand-based
Para amino benzoic acid antagonist - Ligand-based
Peroxisome proliferator-activated receptor agonist - Ligand-based
Peroxisome proliferator-activated receptor gamma agonist - Ligand-based
Phosphodiesterase inhibitor - Ligand-based
Phosphodiesterase V inhibitor - Ligand-based
Phospholipase A2 inhibitor - Ligand-based
Phospholipase inhibitor - Ligand-based
Platelet aggregation inhibitor - Ligand-based
Polarisation inhibitor - Ligand-based
Potassium channel antagonist - Ligand-based
Prostaglandin antagonist - Ligand-based
Prostaglandin synthase inhibitor - Ligand-based
Protease inhibitor - Ligand-based
Reverse transcriptase inhibitor - Ligand-based
Ribonucleoside diphosphate reductase inhibitor - Ligand-based
Ribonucleoside triphosphate reductase inhibitor - Ligand-based
Ribonucleotide reductase inhibitor - Ligand-based
S-adenosyl-L-methionine decarboxylase inhibitor - Ligand-based
Sigma receptor antagonist - Ligand-based
Stromelysin inhibitor - Ligand-based
Substance P antagonist - Ligand-based
Thromboxane A2 antagonist - Ligand-based
Thromboxane antagonist - Ligand-based
Thromboxane synthase inhibitor - Ligand-based
TNF convertase inhibitor - Ligand-based
Topoisomerase inhibitor - Ligand-based
Vanilloid antagonist - Ligand-based
VLA antagonist - Ligand-based
Xanthine oxidase inhibitor - Ligand-based


Otava's Target-Focused Libraries collection
Name Number
Kinases 67
Proteases 12
GPCRs 24
Ion channels 3
Disease-based libraries 29
Epigenetic targets 6
Protein-Protein Interaction 2
Peptidomimetic 1
Nuclear Receptors 1
General Activities 127
Other 101




The libraries (SDF, XLS, PDF format) are available on request. Feel free to contact us or use on-line form below to send an inquiry if you are interested to obtain these libraries or if you need more information.






Need more information regarding this product? Send us an inquiry:

Name: *
Company: *
E-mail: *
Your message
(please specify name of the product
you are interested in):
Word Verification: